Published in Am J Hosp Pharm on August 01, 1979
Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents. Antimicrob Agents Chemother (1983) 1.09
Auditing antibiotic use in a teaching hospital: focus on cefoxitin. Can Med Assoc J (1983) 0.86
Dealing with the misuse of antibiotics in the hospital. Can Med Assoc J (1983) 0.82
The role of the infectious diseases physician in monitoring antimicrobial use: a pharmacy perspective. Bull N Y Acad Med (1987) 0.79
Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med (1991) 7.83
Aetiology of antimicrobial-agent-associated colitis. Lancet (1978) 5.91
Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med (1999) 5.82
Legionnaires' disease: clinical features of 24 cases. Ann Intern Med (1978) 4.30
Laboratory diagnosis of Legionnaires' disease. Am Rev Respir Dis (1980) 3.95
Aspergillosis complicating neoplastic disease. Am J Med (1973) 3.80
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med (1992) 3.65
Isolation of Legionella pneumophila from hospital shower heads. Ann Intern Med (1981) 2.89
Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature. Medicine (Baltimore) (1980) 2.81
Immunologic diagnosis of Legionnaires' disease: cross-reactions with anaerobic and microaerophilic organisms and infections caused by them. J Infect Dis (1980) 2.76
Bacteriology of human and animal bite wounds. J Clin Microbiol (1978) 2.66
Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa. Appl Microbiol (1971) 2.60
Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol (1991) 2.59
Susceptibility of Legionella pneumophila to twenty antimicrobial agents. Antimicrob Agents Chemother (1980) 2.49
Legionnaires' disease: unusual clinical and laboratory features. Ann Intern Med (1980) 2.46
Legionella infections: a review of five years of research. Rev Infect Dis (1983) 2.30
Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J Clin Microbiol (1989) 2.24
Isolation of a new serotype of legionnaires' disease bacterium. Lancet (1978) 2.21
Phycomycosis complicating leukemia and lymphoma. Ann Intern Med (1972) 2.17
Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group. Ann Intern Med (1994) 2.12
Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital. Lancet (1976) 2.07
Isolation of Legionella pneumophila from blood. Lancet (1979) 1.97
Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med (1977) 1.90
Fungal infections in patients with AIDS and AIDS-related complex. Scand J Infect Dis (1986) 1.88
Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.86
Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics. Antimicrob Agents Chemother (1978) 1.81
Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biol Chem (2001) 1.77
Saccharomyces cerevisiae infections in man. Sabouraudia (1984) 1.76
Legionnaires' disease in renal-transplant recipients. Lancet (1978) 1.75
Infectious complications of neoplastic disease. Med Clin North Am (1971) 1.75
Evaluation of a novel specimen transport system (Venturi Transystem) for anaerobic bacteria. Clin Infect Dis (1997) 1.75
Pseudomonas aeruginosa vaccine in cancer patients. Ann Intern Med (1973) 1.73
Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin. Antimicrob Agents Chemother (1981) 1.73
Amikacin therapy for serious gram-negative bacillary infections. Ann Intern Med (1975) 1.70
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis (1996) 1.68
Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans. J Clin Microbiol (1997) 1.68
Susceptibility of Legionella spp. to mycinamicin I and II and other macrolide antibiotics: effects of media composition and origin of organisms. Antimicrob Agents Chemother (1982) 1.68
Nosocomial Legionnaires' disease: a continuing common-source epidemic at Wadsworth Medical Center. Ann Intern Med (1979) 1.66
Role of anaerobic bacteria in bite-wound infections. Rev Infect Dis (1984) 1.66
Cefoxitin: clinical evaluation in thirty-eight patients. Antimicrob Agents Chemother (1977) 1.58
In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics. Antimicrob Agents Chemother (1976) 1.57
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals. Antimicrob Agents Chemother (1985) 1.56
Potable water as a source of Legionnaires' disease. JAMA (1985) 1.56
Infections caused by Klebsiella ozaenae: a changing disease spectrum. J Clin Microbiol (1978) 1.50
Characterization of a beta-lactamase from Clostridium clostridioforme. J Antimicrob Chemother (1994) 1.47
Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure. J Virol (1992) 1.43
Pulmonary infiltrate and pleural effusion in a diabetic man. Clin Infect Dis (1992) 1.41
Survival of aerobic and anaerobic bacteria in purulent clinical specimens maintained in the Copan Venturi Transystem and Becton Dickinson Port-a-Cul transport systems. J Clin Microbiol (2000) 1.41
Legionnaires' disease. Annu Rev Med (1980) 1.35
Susceptibility of Eikenella corrodens to ten cephalosporins. Antimicrob Agents Chemother (1978) 1.35
Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538. Antimicrob Agents Chemother (1978) 1.32
Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles. Clin Infect Dis (1996) 1.31
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. Antimicrob Agents Chemother (1996) 1.27
Frequency of isolation of Porphyromonas species from infected dog and cat bite wounds in humans and their characterization by biochemical tests and arbitrarily primed-polymerase chain reaction fingerprinting. Clin Infect Dis (1996) 1.26
Eikenella corrodens in hand infections. J Hand Surg Am (1983) 1.24
Do hospital employees benefit from the influenza vaccine? A placebo-controlled clinical trial. J Gen Intern Med (1988) 1.23
Group G streptococcal endocarditis. Am J Clin Pathol (1978) 1.22
Effect of carbon dioxide on erythromycin. Antimicrob Agents Chemother (1983) 1.21
Management of human and animal bite wounds. Emerg Med Clin North Am (1985) 1.21
Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species. J Clin Microbiol (1990) 1.21
Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity. Am J Med (1987) 1.21
Dog bite wounds and infection: a prospective clinical study. Ann Emerg Med (1980) 1.19
Susceptibility of Eikenella corrodens to newer beta-lactam antibiotics. Antimicrob Agents Chemother (1980) 1.18
Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy. Antimicrob Agents Chemother (1986) 1.16
Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur J Clin Microbiol Infect Dis (2000) 1.14
Radiographic features of Legionnaires' disease. Chest (1979) 1.13
Surgical anatomy of the medial antebrachial cutaneous nerve. J Hand Surg Am (1989) 1.13
Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens. J Clin Microbiol (1995) 1.12
Identification and strain differentiation of 'Bacteroides fragilis group' species and Prevotella bivia by PCR fingerprinting. Anaerobe (1995) 1.12
New horizons in the bacteriology, antimicrobial susceptibility and therapy of animal bite wounds. J Med Microbiol (1998) 1.11
Disseminated Phialophora parasitica infection in humans: case report and review. Rev Infect Dis (1989) 1.11
Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections. Antimicrob Agents Chemother (1985) 1.11
Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. A randomized trial. Ann Intern Med (1990) 1.10
Evaluation of the RapID CB Plus system for identification of Corynebacterium species and other gram-positive rods. J Clin Microbiol (1998) 1.10
Ligandinuria in nephrotoxic acute tubular necrosis. Kidney Int (1977) 1.10
Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae. Antimicrob Agents Chemother (1976) 1.09
Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents. Antimicrob Agents Chemother (1983) 1.09
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals. Antimicrob Agents Chemother (1986) 1.08
Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine (Baltimore) (1981) 1.07
A selective medium for Fusobacterium spp. J Appl Bacteriol (1991) 1.07
Cutaneous lesions in disseminated mucormycosis. JAMA (1973) 1.07
Infections following clenched-fist injury: a new perspective. J Hand Surg Am (1978) 1.05
Legionnaires' disease. A review. Chest (1984) 1.05
Brain abscess and cerebritis. Rev Infect Dis (1984) 1.05
Comparison of microtiter broth dilution and agar dilution methods for susceptibility testing of Eikenella corrodens. Antimicrob Agents Chemother (1983) 1.04
Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract. Am J Med (1987) 1.03
Isolation of Eikenella corrodens from pulmonary infections. Am Rev Respir Dis (1979) 1.03
Legionnaires' disease. A cause of severe abscess-forming pneumonia. Am J Med (1979) 1.02
Bacteriology of rattlesnake venom and implications for therapy. J Infect Dis (1979) 1.02
Fastidious anaerobe agar compared with Wilkins-Chalgren agar, brain heart infusion agar, and brucella agar for susceptibility testing of Fusobacterium species. Antimicrob Agents Chemother (1990) 1.00
Survival of anaerobic bacteria in various thioglycolate and chopped meat broth formulations. J Clin Microbiol (1995) 1.00
Incidence and clinical significance of anaerobic bacteremia in a community hospital. Clin Infect Dis (1993) 0.99
Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clavulanic acid versus penicillin +/- dicloxacillin. Int J Dermatol (1987) 0.99
Clinical evaluation of moxalactam. Antimicrob Agents Chemother (1982) 0.98
Staphylococcus intermedius: clinical presentation of a new human dog bite pathogen. Ann Emerg Med (1989) 0.97
Prospective comparative study of efficacy and toxicity of netilmicin and amikacin. Antimicrob Agents Chemother (1980) 0.97
Susceptibility of Eikenella corrodens to newer and older quinolones. Antimicrob Agents Chemother (1986) 0.97
Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin. Arch Intern Med (1986) 0.97
Pyomyositis in a patient with the acquired immunodeficiency syndrome. Arch Intern Med (1988) 0.97